|
The complaint trending report review determined that there is no non statistical or adverse trend for the product for the complaint issue.However, as the reagent is unknown, no lot review, performance testing or batch record review could be performed.Statistical process control (spc) charts for architect tsh reagents for low, medium and high control and panel n (normal) testing of architect tsh reagent lots show that this assay is performing within the low, medium and high control and panel limits.A review of the performance of this assay on market was completed.The review shows that the tsh product overall is performing acceptably.The architect tsh assay package insert contains information to address the current customer issue.Based on the available information from the customer site and from the results of this evaluation, there is evidence to reasonably suggest a product malfunction occurred.The device failed to meet performance specifications or otherwise perform as intended at the customer site.However, no systemic issue or product deficiency was identified.Lot/serial number was not provided by the customer; therefore, only a partial udi is known.
|